Vantage Consulting Group Inc Astrazeneca PLC Transaction History
Vantage Consulting Group Inc
- $9.74 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,459Shares Held
490MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.39 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.48 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.9 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.66 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.64 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $262B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...